Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1970 1
1972 2
1974 1
1975 1
1976 3
1977 3
1978 8
1979 9
1980 5
1981 4
1982 8
1983 9
1984 14
1985 12
1986 19
1987 15
1988 14
1989 18
1990 15
1991 26
1992 29
1993 41
1994 49
1995 62
1996 56
1997 68
1998 48
1999 87
2000 66
2001 71
2002 66
2003 83
2004 88
2005 103
2006 92
2007 137
2008 123
2009 142
2010 140
2011 150
2012 184
2013 197
2014 241
2015 222
2016 271
2017 304
2018 283
2019 324
2020 311
2021 367
2022 351
2023 289
2024 126

Text availability

Article attribute

Article type

Publication date

Search Results

4,850 results

Results by year

Filters applied: . Clear all
Page 1
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.
Vokinger KN, Hwang TJ, Carl DL, Laube Y, Ludwig WD, Naci H, Kesselheim AS. Vokinger KN, et al. Lancet Oncol. 2022 Apr;23(4):514-520. doi: 10.1016/S1470-2045(22)00073-0. Epub 2022 Mar 7. Lancet Oncol. 2022. PMID: 35271804
More new drugs with overlapping mechanisms of action and similar approved indications might be expected to decrease prices within drug classes. We compared patterns of price changes for cancer drugs within the same class in the USA and in two European countri …
More new drugs with overlapping mechanisms of action and similar approved indications might be expected to decrease prices within dru …
Health and nutrition economics: diet costs are associated with diet quality.
Lo YT, Chang YH, Lee MS, Wahlqvist ML. Lo YT, et al. Asia Pac J Clin Nutr. 2009;18(4):598-604. Asia Pac J Clin Nutr. 2009. PMID: 19965354 Free article. Review.
Several studies indicate that diet costs are associated with dietary quality and also food safety. Food prices have surged over the past couple of years (2007-9) and raised serious concerns about food security around the world. ...Therefore, people who change …
Several studies indicate that diet costs are associated with dietary quality and also food safety. Food prices have surged ove …
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018).
Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, Kessler RC. Greenberg PE, et al. Pharmacoeconomics. 2021 Jun;39(6):653-665. doi: 10.1007/s40273-021-01019-4. Epub 2021 May 5. Pharmacoeconomics. 2021. PMID: 33950419 Free PMC article.
Societal direct and workplace costs were extrapolated by multiplying NSDUH estimates of the number of people with MDD by the direct and workplace cost estimates per patient. ...Consequently, the composition of 2018 costs changed meaningfully, with 35% …
Societal direct and workplace costs were extrapolated by multiplying NSDUH estimates of the number of people with MDD by the direct a …
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States.
Kim N, Wang J, Burudpakdee C, Song Y, Ramasamy A, Xie Y, Sun R, Kumar N, Wu EQ, Sullivan SD. Kim N, et al. J Manag Care Spec Pharm. 2022 Jul;28(7):740-752. doi: 10.18553/jmcp.2022.28.7.740. J Manag Care Spec Pharm. 2022. PMID: 35737858 Free PMC article.
Drug and health care prices reflect 2021 standardized values. Cost-effectiveness was examined with a willingness-to-pay (WTP) threshold of $150,000 per QALY gained. ...Semaglutide 2.4 mg is cost-effective against all comparators at the prespecified WTP thresh …
Drug and health care prices reflect 2021 standardized values. Cost-effectiveness was examined with a willingness-to-pay (WTP) …
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.
Wong WB, Seetasith A, Hung A, Zullig LL. Wong WB, et al. PLoS One. 2023 Jan 19;18(1):e0280570. doi: 10.1371/journal.pone.0280570. eCollection 2023. PLoS One. 2023. PMID: 36656871 Free PMC article.
BACKGROUND: Insurers manage the cost of specialty medicines via rebates, however it is unclear if the savings are passed on to patients, and whether reducing rebates may lead to changes in patient out-of-pocket (OOP) costs and medication adherence. This study …
BACKGROUND: Insurers manage the cost of specialty medicines via rebates, however it is unclear if the savings are passed on to patien …
Accelerate!
Kotter JP. Kotter JP. Harv Bus Rev. 2012 Nov;90(11):44-52, 54-8, 149. Harv Bus Rev. 2012. PMID: 23155997
The old ways of setting and implementing strategy are failing us, writes the author of Leading Change, in part because we can no longer keep up with the pace of change. ...The network's core is a guiding coalition that represents each level and department in the hie …
The old ways of setting and implementing strategy are failing us, writes the author of Leading Change, in part because we can no long …
Changes in sugar-sweetened beverage purchases across the price distribution after the implementation of a tax in Mexico: a before-and-after analysis.
Salgado Hernández JC, Ng SW, Colchero MA. Salgado Hernández JC, et al. BMC Public Health. 2023 Feb 7;23(1):265. doi: 10.1186/s12889-023-15041-y. BMC Public Health. 2023. PMID: 36750794 Free PMC article.
We merged these price tertiles to household purchases and created average monthly ml/capita/day SSB purchases by price tertile at the city level. ...RESULTS: In the regression adjusted models, we found a statistically significant purchase reduction ranging be …
We merged these price tertiles to household purchases and created average monthly ml/capita/day SSB purchases by price tertile …
Price elasticities of pharmaceuticals in a value based-formulary setting.
Yeung K, Basu A, Hansen RN, Sullivan SD. Yeung K, et al. Health Econ. 2018 Nov;27(11):1788-1804. doi: 10.1002/hec.3801. Epub 2018 Jul 20. Health Econ. 2018. PMID: 30028050
Empirical estimates of price elasticities of demand (PED) for pharmaceuticals suggest that they are relatively price inelastic. ...We first show theoretically that by changing the price of a medication and its substitute in opposite directions, VBF des …
Empirical estimates of price elasticities of demand (PED) for pharmaceuticals suggest that they are relatively price inelastic …
Greenhouse-gas-trading markets.
Sandor R, Walsh M, Marques R. Sandor R, et al. Philos Trans A Math Phys Eng Sci. 2002 Aug 15;360(1797):1889-900. doi: 10.1098/rsta.2002.1038. Philos Trans A Math Phys Eng Sci. 2002. PMID: 12460504
The Chicago Climate Exchange, for which the authors serve as lead designers, is intended to provide an organized carbon-trading market involving energy, industry and carbon sequestration in forests and farms. Trading among these diverse sectors will provide price discovery …
The Chicago Climate Exchange, for which the authors serve as lead designers, is intended to provide an organized carbon-trading market invol …
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.
Rome BN, Feldman WB, Desai RJ, Kesselheim AS. Rome BN, et al. JAMA Netw Open. 2021 May 3;4(5):e218816. doi: 10.1001/jamanetworkopen.2021.8816. JAMA Netw Open. 2021. PMID: 33944925 Free PMC article.
Changes in list prices were correlated with changes in net prices (r = 0.34; P = .002). Overall, changes in out-of-pocket spending were not correlated with changes in list prices (r = 0.14; P = .22) or net prices (r = 0.04; …
Changes in list prices were correlated with changes in net prices (r = 0.34; P = .002). Overall, changes …
4,850 results